GlaxoSmithKline (GSK) is the first to apply studies using Apple’s health data-collecting tool, ResearchKit, helping patients with arthritis.
As reported by www.mobihealthnews.com, the study is called PARADE, which the company says stands for Patient Rheumatoid Arthritis Data in the Real World.
‘We are the first in our industry to use Apple’s ResearchKit as part of our research, this time looking at the impact a patient’s disease has on their day-to-day life,’ the company wrote in a statement on its website.
‘We’re not testing a medicine right now. The medicines development process starts with learning from real patients by including their insights and health goals into our research. That’s exactly the information we hope to gather about rheumatoid arthritis, a debilitating disease which can impact patients’ lives at many levels.’
GSK’s intention is to get 300 rheumatoid arthritis patients to download the app and use a combination of sensors and surveys to report on their joint pain, fatigue, and mood, as well as activity and quality of life.
Read the full story about ResearchKit.
